Tumor lysis syndrome occurring after the administration of rituximab for posttransplant lymphoproliferative disorder.
Tumor lysis syndrome occurring after the administration of rituximab for posttransplant lymphoproliferative disorder. Transplant Proc. 2009 Jun; 41(5):1946-8.